CORNES-&-COMPANY-LTD.
Cornes & Company Ltd. started construction on THE MAGARIGAWA CLUB this past spring in Minamiboso in Chiba Prefecture. In creating the club, Cornes envisions a truly unique driving club, road course, and destination that will offer experiences unattainable at other racing circuits . Located 60minutes from the Tokyo metro area, Tokyo International Airport, and Narita International Airport, the exclusive driving club allows members to enjoy an unparalleled driving experience and spectacular views of Mt. Fuji and Tokyo Bay. In addition to its distinctive 3.5-kilometer driving course, THE MAGARIGAWA CLUB offers recreational options for everyone—not just car enthusiasts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200813005038/en/
The first round of applications for membership are sold out.
Concept
There are a few legendary racetracks in the world today. These spots gain iconic status, becoming destinations for piston-heads. Aiming to put THE MAGARIGAWA CLUB on the map, too, Cornes wants to turn it into an iconic destination by creating an exceptional, world-class driving club.
The name and logomark of the club are based on the kanji “<<<(magarigawa)”. Cornes hopes that MAGARIGAWA’s members will be able to fully immerse themselves in the beautiful natural landscape allowing them to become one with nature and have experiences that they won’t get anywhere else in the world.
Road course
The driving course was designed by the world renown team at Tilke Engineers & Architects. It is the first course in Japan that the team has designed from scratch and features a maximum ascent of 20%, maximum descent of 16%, and an 800-meter long straight, making it a track like no other. It is challenging but also designed for safety, letting drivers focus on the driving experience. Members can drive their automobiles on the course, store them on site, and get maintenance checks before and after driving. They can take one-on-one lessons with professional instructors and explore the potential of their favorite cars in a safe manner. The climate-controlled pit building can accommodate up to 36 vehicles and there are other services and facilities that help ensure a satisfying driving experience.
Other Major Facilities
Clubhouse
The design of the clubhouse combines elements from both traditional Japanese and contemporary architecture. Inside the clubhouse members will find a bar, restaurant, family lounge, gymnasium, 25m swimming pool, spa facilities, and natural hot spring baths. Outside, there is a playground, dog run, and hiking trails.
Owner’s paddocks and long-term garage
Each owner’s paddock provides private indoor parking for up to 4 automobiles and features a spacious floorplan that includes a dining area, living room, and terrace. There is also a long-term car storage facility which is highly secure and climate controlled. On-site mechanics keep members’ vehicles in top condition for driving.
“Magarigawa will be home for car lovers. A sanctuary where members will be able to enjoy and share their passion with friends and family.”
said Kenzo Watari, CEO, Cornes Group.
“It will be the answer to the perennial question – where do you drive an 800 horsepower supercar?”
“The extremely hilly topography offers an astonishing basis for the track and makes the layout absolutely unique in the world.”
said Dr. Carsten Tilke, Managing Director, Tilke Engineers & Architects. “Although we have designed and realized over 80 racetracks worldwide including 19 Formula One circuits, this project was very special to us and we are proud to be part of it.
Drivers will enjoy mid-speed, technical sections as well as two high-speed straights of the 3.5km track, which incorporates highest safety and environmental standards. It will be ideal for all kinds of driver skills. As a car enthusiast and racing driver myself, I can’t wait to drive my first laps at this amazing unique track.”
For more information, visit www.magarigawa.com .
Overview
Name: THE MAGARIGAWA CLUB
Location: Minamiboso, Chiba Prefecture, Japan
Date of opening: Scheduled for late 2022
Total site area: 1,000,000sq.m
Track specs: 3.5km in length, max. ascent: 20%, max. descent: 16％, 800m long straight, 22 corners, elevation change of 250m
Convenient: 60minutes from Tokyo & Haneda Airport
About Cornes & Company Ltd.
Established in 1861, Cornes & Co., Ltd. specializes in the import and sale of electronic components, systems equipment, industrial machinery, laboratory equipment and scientific instruments, apparels, fragrances, kitchenware, and nautical charts and publications and has expanded its business into a wide range of areas including non-life insurance and marine insurance survey. Its subsidiary companies Cornes Motors Ltd. and C.P.S. Ltd, are authorized distributors of Rolls-Royce, Bentley, Ferrari, Lamborghini, and Porsche automobiles. Cornes Motors is the leading ultra luxury automotive dealership in Japan.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200813005038/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom